Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions.

Curatolo P, Bjørnvold M, Dill PE, Ferreira JC, Feucht M, Hertzberg C, Jansen A, Jóźwiak S, Kingswood JC, Kotulska K, Macaya A, Moavero R, Nabbout R, Zonnenberg BA.

Drugs. 2016 Apr;76(5):551-65. doi: 10.1007/s40265-016-0552-9. Review.

PMID:
26927950
2.

New insights into the pathophysiology of the tuberous sclerosis complex: Crosstalk of mTOR- and hippo-YAP pathways in cell growth.

Dill PE, Liang N, Pende M.

Rare Dis. 2015 Feb 23;3(1):e1016701. doi: 10.1080/21675511.2015.1016701. eCollection 2015.

3.

Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex.

Liang N, Zhang C, Dill P, Panasyuk G, Pion D, Koka V, Gallazzini M, Olson EN, Lam H, Henske EP, Dong Z, Apte U, Pallet N, Johnson RL, Terzi F, Kwiatkowski DJ, Scoazec JY, Martignoni G, Pende M.

J Exp Med. 2014 Oct 20;211(11):2249-63. doi: 10.1084/jem.20140341. Epub 2014 Oct 6.

4.

Topical everolimus for facial angiofibromas in the tuberous sclerosis complex. A first case report.

Dill PE, De Bernardis G, Weber P, Lösch U.

Pediatr Neurol. 2014 Jul;51(1):109-13. doi: 10.1016/j.pediatrneurol.2014.02.016. Epub 2014 Mar 1.

PMID:
24810875
5.

Are vigabatrin induced T2 hyperintensities in cranial MRI associated with acute encephalopathy and extrapyramidal symptoms?

Dill P, Datta AN, Weber P, Schneider J.

Eur J Paediatr Neurol. 2013 May;17(3):311-5. doi: 10.1016/j.ejpn.2012.10.009. Epub 2012 Nov 27.

PMID:
23199677
6.

Sepiapterin reductase deficiency: a treatable mimic of cerebral palsy.

Friedman J, Roze E, Abdenur JE, Chang R, Gasperini S, Saletti V, Wali GM, Eiroa H, Neville B, Felice A, Parascandalo R, Zafeiriou DI, Arrabal-Fernandez L, Dill P, Eichler FS, Echenne B, Gutierrez-Solana LG, Hoffmann GF, Hyland K, Kusmierska K, Tijssen MA, Lutz T, Mazzuca M, Penzien J, Poll-The BT, Sykut-Cegielska J, Szymanska K, Thöny B, Blau N.

Ann Neurol. 2012 Apr;71(4):520-30. doi: 10.1002/ana.22685.

PMID:
22522443
7.

Increased incidence of Guillain-Barré syndrome after surgery.

Gensicke H, Datta AN, Dill P, Schindler C, Fischer D.

Eur J Neurol. 2012 Sep;19(9):1239-44. doi: 10.1111/j.1468-1331.2012.03730.x. Epub 2012 Apr 23.

PMID:
22519650
8.

Vigabatrin-induced forced normalization and psychosis--prolongated termination of behavioral symptoms but persistent antiepileptic effect after withdrawal.

Weber P, Dill P, Datta AN.

Epilepsy Behav. 2012 May;24(1):138-40. doi: 10.1016/j.yebeh.2012.03.005. Epub 2012 Apr 12.

PMID:
22503470
9.

Child neurology: paroxysmal stiffening, upward gaze, and hypotonia: hallmarks of sepiapterin reductase deficiency.

Dill P, Wagner M, Somerville A, Thöny B, Blau N, Weber P.

Neurology. 2012 Jan 31;78(5):e29-32. doi: 10.1212/WNL.0b013e3182452849. No abstract available.

PMID:
22291068
10.

High resolution array in the clinical approach to chromosomal phenotypes.

Filges I, Suda L, Weber P, Datta AN, Fischer D, Dill P, Glanzmann R, Benzing J, Hegi L, Wenzel F, Huber AR, Mori AC, Miny P, Röthlisberger B.

Gene. 2012 Mar 10;495(2):163-9. doi: 10.1016/j.gene.2011.12.042. Epub 2012 Jan 3.

PMID:
22240311
11.

Pyridoxal phosphate-responsive seizures in a patient with cerebral folate deficiency (CFD) and congenital deafness with labyrinthine aplasia, microtia and microdontia (LAMM).

Dill P, Schneider J, Weber P, Trachsel D, Tekin M, Jakobs C, Thöny B, Blau N.

Mol Genet Metab. 2011 Nov;104(3):362-8. doi: 10.1016/j.ymgme.2011.05.019. Epub 2011 Jun 2.

PMID:
21752681
12.

Examining factors in the Research Institute on Addictions Self-Inventory (RIASI): Associations with alcohol use and problems at assessment and follow-up.

Mann RE, Stoduto G, Zalcman RF, Nochajski TH, Hall L, Dill P, Wells-Parker E.

Int J Environ Res Public Health. 2009 Nov;6(11):2898-918. doi: 10.3390/ijerph6112898. Epub 2009 Nov 24.

13.

Negative affect and drinking drivers: a review and conceptual model linking dissonance, efficacy and negative affect to risk and motivation for change.

Wells-Parker E, Mann RE, Dill PL, Stoduto G, Shuggi R, Cross GW.

Curr Drug Abuse Rev. 2009 May;2(2):115-26. Review.

PMID:
19630742
14.

Fetal magnetic resonance imaging in midline malformations of the central nervous system and review of the literature.

Dill P, Poretti A, Boltshauser E, Huisman TA.

J Neuroradiol. 2009 Jun;36(3):138-46. doi: 10.1016/j.neurad.2008.12.001. Epub 2009 Jan 20. Review.

PMID:
19157551
15.

Examining the link between drinking-driving and depressed mood.

Stoduto G, Dill P, Mann RE, Wells-Parker E, Toneatto T, Shuggi R.

J Stud Alcohol Drugs. 2008 Sep;69(5):777-80.

PMID:
18781254
16.

The relationship between depressed mood, self-efficacy and affective states during the drinking driving sequence.

Dill PL, Wells-Parker E, Cross GW, Williams M, Mann RE, Stoduto G, Shuggi R.

Addict Behav. 2007 Aug;32(8):1714-8. Epub 2006 Dec 22.

PMID:
17188432
17.

Court-mandated treatment for convicted drinking drivers.

Dill PL, Wells-Parker E.

Alcohol Res Health. 2006;29(1):41-8.

18.

Are depressed drinking/driving offenders more receptive to brief intervention?

Wells-Parker E, Dill P, Williams M, Stoduto G.

Addict Behav. 2006 Feb;31(2):339-50. Epub 2005 Jul 6.

PMID:
16005159
19.

Prevalence of mental illness and substance abuse disorders among incarcerated juvenile offenders in Mississippi.

Robertson AA, Dill PL, Husain J, Undesser C.

Child Psychiatry Hum Dev. 2004 Fall;35(1):55-74.

PMID:
15626325
20.

The emergency care setting for screening and intervention for alcohol use problems among injured and high-risk drivers: a review.

Dill PL, Wells-Parker E, Soderstrom CA.

Traffic Inj Prev. 2004 Sep;5(3):278-91. Review.

PMID:
15276929
21.

Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials.

Haddock CK, Poston WS, Dill PL, Foreyt JP, Ericsson M.

Int J Obes Relat Metab Disord. 2002 Feb;26(2):262-73.

PMID:
11850760
22.

The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes.

Brossart P, Schneider A, Dill P, Schammann T, Grünebach F, Wirths S, Kanz L, Bühring HJ, Brugger W.

Cancer Res. 2001 Sep 15;61(18):6846-50.

23.

Lifestyle treatments in randomized clinical trials of pharmacotherapies for obesity.

Poston WS, Haddock CK, Dill PL, Thayer B, Foreyt JP.

Obes Res. 2001 Sep;9(9):552-63.

24.

Dendritic cell-based vaccines in patients with hematological malignancies.

Brugger W, Schneider A, Schammann T, Dill P, Grünebach F, Bühring HJ, Kanz L, Brossart P.

Ann N Y Acad Sci. 2001 Jun;938:359-62; discussion 362-3.

PMID:
11458523
25.

Reliability and validity of the dieter's inventory of eating temptations (DIET) in overweight binge eating women.

Bunn C, Poston WS 2nd, Haddock CK, Dill P, Goodrick GK, Foreyt JP.

Eat Disord. 2000 Winter;8(4):299-309. doi: 10.1080/10640260008251238.

PMID:
27177302
26.

An examination of body weight standards and the association between weight and health behaviors in the United States Air Force.

Haddock CK, Poston WS, Klesges RC, Talcott GW, Lando H, Dill PL.

Mil Med. 1999 Jan;164(1):51-4.

PMID:
9922645
27.

Stages of change and self-efficacy for controlling drinking and driving: a psychometric analysis.

Wells-Parker E, Williams M, Dill P, Kenne D.

Addict Behav. 1998 May-Jun;23(3):351-63.

PMID:
9668932
28.

Stressors of college: a comparison of traditional and nontraditional students.

Dill PL, Henley TB.

J Psychol. 1998 Jan;132(1):25-32.

PMID:
9447723
29.

Exposure to biogenic silica fibers and respiratory health in Hawaii sugarcane workers.

Sinks T, Hartle R, Boeniger M, Mannino D, Boyd JE, Fernback J, Hawkins M, Grimes G, Watkins KL, Dill P, et al.

J Occup Med. 1994 Dec;36(12):1329-34.

PMID:
7884574
30.

The association between CNS direct care time and total time and very low birth weight infant outcomes.

Damato EG, Dill PZ, Gennaro S, Brown LP, York R, Brooten D.

Clin Nurse Spec. 1993 Mar;7(2):75-9.

PMID:
8364834
31.

Renal cell cancer among paperboard printing workers.

Sinks T, Lushniak B, Haussler BJ, Sniezek J, Deng JF, Roper P, Dill P, Coates R.

Epidemiology. 1992 Nov;3(6):483-9.

PMID:
1420513
32.

Chemotherapy of non-small cell lung carcinoma guided by an in vitro drug resistance assay measuring total tumour cell kill.

Wilbur DW, Camacho ES, Hilliard DA, Dill PL, Weisenthal LM.

Br J Cancer. 1992 Jan;65(1):27-32.

33.

Marketing the nursing practice of obstetrics.

Dill PZ.

J Obstet Gynecol Neonatal Nurs. 1991 Jul-Aug;20(4):328-32.

PMID:
1941295
34.

Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Fingerhut MA, Halperin WE, Marlow DA, Piacitelli LA, Honchar PA, Sweeney MH, Greife AL, Dill PA, Steenland K, Suruda AJ.

N Engl J Med. 1991 Jan 24;324(4):212-8.

35.
36.

Perturbation of in vitro drug resistance in human lymphatic neoplasms by combinations of putative inhibitors of protein kinase C.

Weisenthal LM, Su YZ, Duarte TE, Dill PL, Nagourney RA.

Cancer Treat Rep. 1987 Dec;71(12):1239-43.

PMID:
3480042
37.

Selective enhancement by menadiol of in vitro drug activity in human lymphatic neoplasms.

Su YZ, Duarte TE, Dill PL, Weisenthal LM.

Cancer Treat Rep. 1987 Jun;71(6):619-25.

PMID:
3581100
38.

Laboratory detection of primary and acquired drug resistance in human lymphatic neoplasms.

Weisenthal LM, Dill PL, Finklestein JZ, Duarte TE, Baker JA, Moran EM.

Cancer Treat Rep. 1986 Nov;70(11):1283-95.

PMID:
2429763
39.

[The Hochwald airplane crash on 10 April 1973].

Leutenegger A, Dill P.

Z Unfallchir Versicherungsmed Berufskr. 1985;78(3):145-51. German. No abstract available.

PMID:
3938128
40.

In vitro chemosensitivity assay based on the concept of total tumor cell kill.

Weisenthal LM, Shoemaker RH, Marsden JA, Dill PL, Baker JA, Moran EM.

Recent Results Cancer Res. 1984;94:161-73. No abstract available.

PMID:
6494576
41.

A novel dye exclusion method for testing in vitro chemosensitivity of human tumors.

Weisenthal LM, Marsden JA, Dill PL, Macaluso CK.

Cancer Res. 1983 Feb;43(2):749-57.

PMID:
6184155
42.

Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity.

Weisenthal LM, Dill PL, Kurnick NB, Lippman ME.

Cancer Res. 1983 Jan;43(1):258-64.

Supplemental Content

Support Center